BIOREM Inc.
BIRMF
$1.49
$0.04363.01%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.38% | 26.84% | 46.66% | 67.53% | 18.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.38% | 26.84% | 46.66% | 67.53% | 18.97% |
| Cost of Revenue | 27.44% | 36.23% | 48.55% | 56.91% | 17.11% |
| Gross Profit | 7.47% | 6.02% | 41.78% | 95.81% | 23.48% |
| SG&A Expenses | 25.91% | 26.44% | 41.90% | 11.65% | -20.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -3,200.00% | -- |
| Total Operating Expenses | 26.91% | 34.21% | 47.17% | 46.80% | 8.31% |
| Operating Income | -8.35% | -12.12% | 43.04% | 388.58% | 152.85% |
| Income Before Tax | -7.81% | -7.57% | 48.12% | 545.93% | 217.50% |
| Income Tax Expenses | 3.80% | 6.02% | 78.86% | 298.31% | 106.65% |
| Earnings from Continuing Operations | -11.41% | -11.69% | 39.44% | 710.35% | 280.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.41% | -11.69% | 39.44% | 710.35% | 280.80% |
| EBIT | -8.35% | -12.12% | 43.04% | 388.58% | 152.85% |
| EBITDA | -2.46% | -5.90% | 46.75% | 345.47% | 129.18% |
| EPS Basic | -12.16% | -12.07% | 39.51% | 691.83% | 271.33% |
| Normalized Basic EPS | -8.61% | -7.93% | 48.34% | 531.76% | 209.66% |
| EPS Diluted | -31.44% | -34.17% | 10.97% | 730.43% | 334.52% |
| Normalized Diluted EPS | -13.76% | -13.77% | 40.87% | 716.06% | 272.12% |
| Average Basic Shares Outstanding | 5.21% | 4.69% | -0.09% | 0.57% | 0.73% |
| Average Diluted Shares Outstanding | 0.66% | 4.71% | 7.84% | 5.43% | 4.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |